Neuronetics Inc (STIM)
1.13
+0.04
(+3.20%)
USD |
NASDAQ |
Nov 05, 11:30
Neuronetics Enterprise Value: 49.60M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
November 04, 2024 | 49.60M |
November 01, 2024 | 47.64M |
October 31, 2024 | 47.64M |
October 30, 2024 | 48.85M |
October 29, 2024 | 47.03M |
October 28, 2024 | 46.46M |
October 25, 2024 | 46.42M |
October 24, 2024 | 45.82M |
October 23, 2024 | 45.89M |
October 22, 2024 | 46.73M |
October 21, 2024 | 46.73M |
October 18, 2024 | 45.84M |
October 17, 2024 | 44.00M |
October 16, 2024 | 44.18M |
October 15, 2024 | 43.39M |
October 14, 2024 | 43.39M |
October 11, 2024 | 44.00M |
October 10, 2024 | 42.49M |
October 09, 2024 | 44.30M |
October 08, 2024 | 42.49M |
October 07, 2024 | 40.67M |
October 04, 2024 | 42.18M |
October 03, 2024 | 40.36M |
October 02, 2024 | 39.15M |
October 01, 2024 | 39.15M |
Date | Value |
---|---|
September 30, 2024 | 39.45M |
September 27, 2024 | 39.15M |
September 26, 2024 | 40.06M |
September 25, 2024 | 40.31M |
September 24, 2024 | 41.88M |
September 23, 2024 | 43.09M |
September 20, 2024 | 44.60M |
September 19, 2024 | 45.13M |
September 18, 2024 | 45.05M |
September 17, 2024 | 45.27M |
September 16, 2024 | 40.06M |
September 13, 2024 | 38.58M |
September 12, 2024 | 38.85M |
September 11, 2024 | 38.92M |
September 10, 2024 | 40.06M |
September 09, 2024 | 40.06M |
September 06, 2024 | 39.91M |
September 05, 2024 | 40.16M |
September 04, 2024 | 41.35M |
September 03, 2024 | 42.64M |
August 30, 2024 | 43.18M |
August 29, 2024 | 42.18M |
August 28, 2024 | 43.04M |
August 27, 2024 | 44.28M |
August 26, 2024 | 45.12M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-21.54M
Minimum
Mar 23 2020
456.15M
Maximum
Feb 16 2021
88.30M
Average
56.84M
Median
Enterprise Value Benchmarks
Quest Diagnostics Inc | 22.82B |
Delcath Systems Inc | 286.14M |
Star Equity Holdings Inc | 39.25M |
CytoSorbents Corp | 52.60M |
Progyny Inc | 1.105B |
Enterprise Value Related Metrics
Net Income (Quarterly) | -9.832M |
Revenue (Quarterly) | 16.45M |
Total Expenses (Quarterly) | 24.96M |
EPS Diluted (Quarterly) | -0.33 |
Gross Profit Margin (Quarterly) | 74.04% |
Profit Margin (Quarterly) | -59.77% |
Earnings Yield | -99.12% |
Normalized Earnings Yield | -99.12 |